bezuclastinib PDUFA date

The PDUFA goal date for bezuclastinib (CGT9486) in GIST is 30 Nov 2026, as disclosed by Cogent Biosciences, Inc. (COGT).

PDUFA date
30 Nov 2026
Condition
GIST

Drug identity checked against registry records

Also recorded as CGT9486; PLX9486

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisNCT04996875COGTPhase 2Recruiting2025-09-19Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-11-30DaybezuclastinibCogent Biosciences, Inc. · COGTCompany-disclosed PDUFA goal dateAnnounced review targetGISTOpen original source
Read source excerpt

Preparing for anticipated bezuclastinib launch in GIST; PDUFA action date November 30, 2026

First seen: 07 Nov 2026 · Evidence last checked: 07 Nov 2026

2026-12-30DaybezuclastinibCogent Biosciences, Inc. · COGTCompany-disclosed PDUFA goal dateAnnounced review targetNonAdvSMOpen original source
Read source excerpt

We submitted the first NDA for bezuclastinib in patients with NonAdvSM in December 2025, which was accepted by the FDA in March 2026. The FDA assigned a Prescription Drug User Fee Act ("PDUFA") target action date of December 30, 2026.

First seen: 07 Nov 2026 · Evidence last checked: 07 Nov 2026

2026-12-30DaybezuclastinibCogent Biosciences, Inc. · COGTCompany-disclosed PDUFA goal dateAnnounced review targetNonAdvSMOpen original source
Read source excerpt

Potential FDA approval of bezuclastinib in NonAdvSM – PDUFA date of December 30, 2026

First seen: 08 Nov 2026 · Evidence last checked: 08 Nov 2026

2027-06-29DaybezuclastinibCogent Biosciences, Inc. · COGTCompany-disclosed PDUFA goal dateAnnounced review targetAdvSMOpen original source
Read source excerpt

Potential FDA approval of bezuclastinib in AdvSM – PDUFA date of June 29, 2027

First seen: 08 Nov 2026 · Evidence last checked: 08 Nov 2026